Prognostic factors and survival rates for parotid duct carcinoma patients

To investigate the survival rates of patients diagnosed with parotid duct carcinoma (PDC) and analyze the associated risk factors.

This study included 38 patients with PDC and the following information was collected for each patient: gender, age, tumor size, TNM classification, neck node metastasis, House-Brackmann grade, neural invasion, use of postoperative radiation therapy and survival data. The Kaplan-Meier method and the Cox model were used to determine prognostic factors for disease-specific survival (DSS) and recurrence-free survival (RFS) rates.

Of the 38 patients, 36 (94.7%) were male. Mean age at initial diagnosis was 59.9 years (range: 43-79). A total of 32 (84.2%) patients had T3/T4 tumors, and 29 (76.3%) patients had a preoperative House-Brackmann grade of I/II. A correlation analysis showed that tumor stage was significantly associated with House-Brackmann grade (Spearman r = 0.521, p = 0.001). The 5-year DSS and RFS rates were 45% and 30%, respectively. Using Cox-regression analysis, node metastasis and the preoperative House-Brackmann grade were the independent predictors of both RFS and DSS. Postoperative radiation could decrease disease recurrence, but did not improve disease-specific survival.

Parotid duct carcinoma is an aggressive tumor. Node status and preoperative House-Brackmann grade are key prognostic factors.